This drug course, often known as GLP-one agonists, includes semaglutide—accepted as Ozempic for variety 2 diabetic issues and Wegovy for obesity—and tirzepatide—authorized as Mounjaro for diabetes and Zepbound https://barryhrww495755.homewikia.com/user